These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22238432)

  • 81. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
    Tan EL; Looi LM; Sam CK
    Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Diagnostic testing in Epstein-Barr virus infection.
    Kudo T; Egawa H; Kuzushima K; Kimura H; Morishima T; Ichiyama S
    Clin Chem Lab Med; 2001 Sep; 39(9):789-94. PubMed ID: 11601674
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Epstein-Barr virus DNAemia in Iranian liver transplant recipients and assessment of its variation in posttransplant lymphproliferative disorder patients by quantitative polymerase chain reaction assay.
    Jamalidoust M; Geramizadeh B; Pouladfar G; Namayandeh M; Asaie S; Aliabadi N; Nikeghbalian S; Ziyaeyan M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():306-11. PubMed ID: 25894179
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Human cytomegalovirus and Epstein-Barr virus infection in inflammatory bowel disease: need for mucosal viral load measurement.
    Ciccocioppo R; Racca F; Paolucci S; Campanini G; Pozzi L; Betti E; Riboni R; Vanoli A; Baldanti F; Corazza GR
    World J Gastroenterol; 2015 Feb; 21(6):1915-26. PubMed ID: 25684960
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.
    Lee TC; Savoldo B; Barshes NR; Rooney CM; Heslop HE; Gee AP; Caldwell Y; Scott JD; Goss JA
    Clin Transplant; 2006; 20(3):389-93. PubMed ID: 16824159
    [TBL] [Abstract][Full Text] [Related]  

  • 86. A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2.
    Gatto F; Cassina G; Broccolo F; Morreale G; Lanino E; Di Marco E; Vardas E; Bernasconi D; Buttò S; Principi N; Esposito S; Scarlatti G; Lusso P; Malnati MS
    J Virol Methods; 2011 Dec; 178(1-2):98-105. PubMed ID: 21903135
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Multicenter comparison of different real-time PCR assays for quantitative detection of Epstein-Barr virus.
    Hayden RT; Hokanson KM; Pounds SB; Bankowski MJ; Belzer SW; Carr J; Diorio D; Forman MS; Joshi Y; Hillyard D; Hodinka RL; Nikiforova MN; Romain CA; Stevenson J; Valsamakis A; Balfour HH;
    J Clin Microbiol; 2008 Jan; 46(1):157-63. PubMed ID: 17989187
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease.
    Gärtner BC; Schäfer H; Marggraff K; Eisele G; Schäfer M; Dilloo D; Roemer K; Laws HJ; Sester M; Sester U; Einsele H; Mueller-Lantzsch N
    J Clin Microbiol; 2002 Feb; 40(2):351-8. PubMed ID: 11825941
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Multicenter Evaluation of Whole-Blood Epstein-Barr Viral Load Standardization Using the WHO International Standard.
    Semenova T; Lupo J; Alain S; Perrin-Confort G; Grossi L; Dimier J; Epaulard O; Morand P; Germi R
    J Clin Microbiol; 2016 Jul; 54(7):1746-1750. PubMed ID: 27076661
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A; Nazzari C; Verzaro S; Latte MC; Fabri G; Scateni S; Raggi C; Lubrano R; Mancini C
    New Microbiol; 2006 Oct; 29(4):231-41. PubMed ID: 17201089
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients.
    Stevens SJ; Verschuuren EA; Pronk I; van Der Bij W; Harmsen MC; The TH; Meijer CJ; van Den Brule AJ; Middeldorp JM
    Blood; 2001 Mar; 97(5):1165-71. PubMed ID: 11222357
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Polymerase Chain Reaction and Goldmann-Witmer Coefficient to Examine the Role of Epstein-Barr Virus in Uveitis.
    Smit D; Meyer D; Maritz J; de Groot-Mijnes JDF
    Ocul Immunol Inflamm; 2019; 27(1):108-113. PubMed ID: 29039992
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases.
    Meerbach A; Gruhn B; Egerer R; Reischl U; Zintl F; Wutzler P
    J Med Virol; 2001 Oct; 65(2):348-57. PubMed ID: 11536243
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Prompt versus preemptive intervention for EBV lymphoproliferative disease.
    Wagner HJ; Cheng YC; Huls MH; Gee AP; Kuehnle I; Krance RA; Brenner MK; Rooney CM; Heslop HE
    Blood; 2004 May; 103(10):3979-81. PubMed ID: 14751931
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cellular normalization of viral DNA loads on whole blood improves the clinical management of cytomegalovirus or Epstein Barr virus infections in the setting of pre-emptive therapy.
    Bressollette-Bodin C; Coste-Burel M; Besse B; André-Garnier E; Ferre V; Imbert-Marcille BM
    J Med Virol; 2009 Jan; 81(1):90-8. PubMed ID: 19031462
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Evaluation of the LightCycler 480 real-time PCR system for the measurement of CMV, EBV, HHV-6 and BKV viral loads in whole blood].
    Boutolleau D; Deback C; Géli J; Aït-Arkoub Z; Angleraud F; Gautheret-Dejean A; Agut H
    Pathol Biol (Paris); 2010 Apr; 58(2):166-9. PubMed ID: 19892483
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of different RNA extraction methods and storage conditions of dried plasma or blood spots for human immunodeficiency virus type 1 RNA quantification and PCR amplification for drug resistance testing.
    Monleau M; Montavon C; Laurent C; Segondy M; Montes B; Delaporte E; Boillot F; Peeters M
    J Clin Microbiol; 2009 Apr; 47(4):1107-18. PubMed ID: 19193835
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Applicability of the cobas 6800 System for Epstein-Barr viral load quantitation using whole-blood specimens.
    Song J; Kim S; Kwak E; Park Y
    Am J Clin Pathol; 2024 Mar; 161(3):273-282. PubMed ID: 37936258
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.